1.
Devolder MEC, Pereira ST, Pinto RFM, et al. CLINICAL OUTCOMES OF LONG-TERM USE OF SGLT2 INHIBITORS IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE. REASE. 2024;10(8):2042-2052. doi:10.51891/rease.v10i8.15327